Dr. David S. Dimarco, MD

Dr. Dimarco practices at Oregon Surgi Center in Springfield, Oregon.

Dr. Dimarco's NPI, 1174540751, was assigned on July 17, 2006. Dr. Dimarco graduated from Saint Louis University School Of Medicine in 1998. Dr. Dimarco's Oregon license number on file is MD26099.

Dr. Dimarco's primary practice is Oregon Surgi Center, at 2400 Hartman Lane, Suite 300, Springfield, OR 97477. The practice phone is (541) 343-1603.

Dr. Dimarco's primary practice is Oregon Surgi Center in Springfield, Oregon. Dr. Dimarco is also affiliated with PeaceHealth Sacred Heart Medical Center RiverBend. The medical group on file is Oregon Urology Institute. Dmand AI also links Dr. Dimarco to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimarco practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dimarco's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dimarco is board certified in urology by the American Board of Urology. Dmand AI has Dr. Dimarco's licenses on file in 3 states: Oregon, Arizona and Minnesota.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Dimarco treats.

CMS data shows 5,050 Medicare services from Dr. Dimarco across 28 procedure codes in 2024, for 521 Medicare patients. Medicare paid $82,274 for them.

CMS counts 521 Medicare patients who saw Dr. Dimarco in 2024. The largest group is 65 to 74, with 223 patients. 70% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dimarco's median patient age at 73, with 22% women.

In 2024, Dr. Dimarco wrote 1,291 Medicare Part D claims for 389 patients. 81% of them were for generic drugs. CMS names the drug for 1,157 of them, across 21 drugs with 11 or more claims each, at $912,130 in total drug cost. In 2023, CMS named 917 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Dimarco for performance year 2024, reported as part of a group. Dr. Dimarco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dimarco as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Dimarco, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Dimarco, published from 2006 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Prostatectomy. Dr. Dimarco has published most often in J Urol. Dr. Dimarco's most frequent co-authors are Daniel S. Elliott, MD, Christopher H. Cantrill, MD and Karl Joseph Coutinho, MD.

Dmand AI links Dr. Dimarco to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urethral Stricture and Urethral Obstruction.

CMS Open Payments shows 135 general payments to Dr. Dimarco from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 35% of the total. UroGPO LLC paid the most, $6,418.

Dmand AI lists 1 award for Dr. Dimarco, most recently CMS Stage 1 2012 in 2011.

Dr. Dimarco graduated from Saint Louis University School Of Medicine in 1998.

Dr. Dimarco is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.